198 related articles for article (PubMed ID: 11426751)
1. Ivor Lewis esophagogastrectomy for esophageal cancer.
Visbal AL; Allen MS; Miller DL; Deschamps C; Trastek VF; Pairolero PC
Ann Thorac Surg; 2001 Jun; 71(6):1803-8. PubMed ID: 11426751
[TBL] [Abstract][Full Text] [Related]
2. Subtotal esophagectomy with extended 2-field lymph node dissection for thoracic esophageal cancer.
Stilidi I; Davydov M; Bokhyan V; Suleymanov E
Eur J Cardiothorac Surg; 2003 Mar; 23(3):415-20. PubMed ID: 12614816
[TBL] [Abstract][Full Text] [Related]
3. Esophageal resection for cancer of the esophagus: long-term function and quality of life.
McLarty AJ; Deschamps C; Trastek VF; Allen MS; Pairolero PC; Harmsen WS
Ann Thorac Surg; 1997 Jun; 63(6):1568-72. PubMed ID: 9205149
[TBL] [Abstract][Full Text] [Related]
4. Inkwelling increases benign stricture formation after Ivor Lewis esophagogastrectomy.
Akowuah E; Junemann-Ramirez M; Kalejayie O; Rahamim J
J Thorac Cardiovasc Surg; 2007 Feb; 133(2):581-2. PubMed ID: 17258611
[No Abstract] [Full Text] [Related]
5. Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma.
Swanson SJ; Batirel HF; Bueno R; Jaklitsch MT; Lukanich JM; Allred E; Mentzer SJ; Sugarbaker DJ
Ann Thorac Surg; 2001 Dec; 72(6):1918-24; discussion 1924-5. PubMed ID: 11789772
[TBL] [Abstract][Full Text] [Related]
6. Ivor Lewis esophagogastrectomy for carcinoma of the esophagus: early and late functional results.
King RM; Pairolero PC; Trastek VF; Payne WS; Bernatz PE
Ann Thorac Surg; 1987 Aug; 44(2):119-22. PubMed ID: 3619535
[TBL] [Abstract][Full Text] [Related]
7. Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival.
Donahue JM; Nichols FC; Li Z; Schomas DA; Allen MS; Cassivi SD; Jatoi A; Miller RC; Wigle DA; Shen KR; Deschamps C
Ann Thorac Surg; 2009 Feb; 87(2):392-8; discussion 398-9. PubMed ID: 19161745
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy comparison of Sweet versus Ivor-Lewis esophagectomy in the treatment of middle-lower esophageal squamous cell carcinoma].
Yang X; Zhan C; Sun F; Chen L; Shi M; Jiang W; Wang Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):979-984. PubMed ID: 27680063
[TBL] [Abstract][Full Text] [Related]
9. [Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus].
Wu J; Chai Y; Zhou XM; Chen QX; Yan FL
Ai Zheng; 2007 Mar; 26(3):307-11. PubMed ID: 17355797
[TBL] [Abstract][Full Text] [Related]
10. Survival After Surgical Resection of Stage IV Esophageal Cancer.
Saddoughi SA; Reinersman JM; Zhukov YO; Taswell J; Mara K; Harmsen SW; Blackmon SH; Cassivi SD; Nichols F; Shen KR; Wigle DA; Allen MS
Ann Thorac Surg; 2017 Jan; 103(1):261-266. PubMed ID: 27623270
[TBL] [Abstract][Full Text] [Related]
11. Minimally invasive esophagectomy provides equivalent oncologic outcomes to open esophagectomy for locally advanced (stage II or III) esophageal carcinoma.
Singh RK; Pham TH; Diggs BS; Perkins S; Hunter JG
Arch Surg; 2011 Jun; 146(6):711-4. PubMed ID: 21690448
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes of 530 esophageal squamous cell carcinoma patients with minimally invasive Ivor Lewis esophagectomy.
Qi W; Zixiang W; Tianwei Z; Shuai F; Sai Z; Gang S; Ming W
J Surg Oncol; 2018 Apr; 117(5):957-969. PubMed ID: 29878389
[TBL] [Abstract][Full Text] [Related]
13. Incidence and management of chylothorax after Ivor Lewis esophagectomy for cancer of the esophagus.
Brinkmann S; Schroeder W; Junggeburth K; Gutschow CA; Bludau M; Hoelscher AH; Leers JM
J Thorac Cardiovasc Surg; 2016 May; 151(5):1398-404. PubMed ID: 26936011
[TBL] [Abstract][Full Text] [Related]
14. Effect of body mass index on operative outcome after robotic-assisted Ivor-Lewis esophagectomy: retrospective analysis of 129 cases at a single high-volume tertiary care center.
Salem AI; Thau MR; Strom TJ; Abbott AM; Saeed N; Almhanna K; Hoffe SE; Shridhar R; Karl RC; Meredith KL
Dis Esophagus; 2017 Jan; 30(1):1-7. PubMed ID: 27149640
[TBL] [Abstract][Full Text] [Related]
15. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
[TBL] [Abstract][Full Text] [Related]
16. Resection for esophageal carcinoma at a Virginia hospital 1981-1989.
Kiernan PD; Sheridan MJ; Byrne WD; Fulcher TM; Conte J; Corcoran PC; Pagani F; Seigel L
Va Med Q; 1993; 120(1):33-6. PubMed ID: 8420567
[TBL] [Abstract][Full Text] [Related]
17. [Results on Ivor-Lewis esophagogastrectomy for 338 cases of carcinoma of esophagus].
Wu C; Zhang Z; Xue H
Zhonghua Zhong Liu Za Zhi; 1996 May; 18(3):192-4. PubMed ID: 9387252
[TBL] [Abstract][Full Text] [Related]
18. Initial experience of total thoracoscopic and laparoscopic Ivor Lewis esophagectomy.
Merritt RE
J Laparoendosc Adv Surg Tech A; 2012 Apr; 22(3):214-9. PubMed ID: 22393924
[TBL] [Abstract][Full Text] [Related]
19. [The local control of radiotherapy following Ivor-Lewis esophagectomy in the patients with stage II A middle-third thoracic esophageal cancer].
Zhang MY; Wang Z; Liu XY; Chen G; Liu FY
Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(14):1048-50. PubMed ID: 19094527
[TBL] [Abstract][Full Text] [Related]
20. Survival after esophageal resection for carcinoma: the importance of the histologic cell type.
Alexiou C; Khan OA; Black E; Field ML; Onyeaka P; Beggs L; Duffy JP; Beggs DF
Ann Thorac Surg; 2006 Sep; 82(3):1073-7. PubMed ID: 16928541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
